Israeli delegation at TEDMED

Israel is the first country to be represented at the TEDMED healthcare conference in Washington by an official delegation.

Israeli representatives are taking part in the TEDMED medical technology and healthcare conference, which opened in Washington DC on Tuesday. Among the members of the Israeli delegation are Judith Richter, joint founder and CEO of Medinol, Miki Haimovich, Dr. Yehuda Livneh, general patent counsel at Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), and Dr. Nurit Harel, co-chair of Fischer Pharmaceutical and a member of the governing body of the Manufacturers Association of Israel. In parallel, events are taking place today at the Peres Center for Peace, at which Israeli speakers will appear, while selected presentations will be transmitted live from the Washington conference.

Israel is the first country to be represented at the TEDMED conference by an official delegation. The conference runs until Friday. The members of the delegation were chosen to represent various aspects of innovation in industry relating to healthcare and the life sciences, and to introduce conference participants to the array of innovation taking place in Israel.

The delegation is led by Dr. Eitan Eliram, ambassador of Singularity University in Israel. He and his brother Adv. Yaron Eliram were chosen as the official representatives of TEDMED in Israel.

TEDMED is a multi-disciplinary community of innovators and leaders who share a determination to create a better future in health and medicine. A three-day conference is held annually at which the world's foremost lecturers and innovators in health and medicine present ideas that in many cases become the next big thing in their fields. The lectures become very popular items on the Internet when they are released.

Published by Globes [online], Israel business news - www.globes-online.com - on April 18, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס